Literature DB >> 17440718

Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1alpha and its transcription activity.

Yasushi Kawaguchi1, Akiko Tochimoto, Masako Hara, Manabu Kawamoto, Tomoko Sugiura, Seiji Saito, Naoyuki Kamatani.   

Abstract

We previously demonstrated the association of IL1A gene single nucleotide polymorphisms (SNPs) with susceptibility to systemic sclerosis (SSc) patients. In this study, we explored the effects of SNP on the transcriptional activity and processing of the precursor IL-1alpha (pre-IL-1alpha) in skin fibroblasts. Two kinds of promoter regions of the IL1A gene were prepared including C or T at -889, referred to C/IL1A and T/IL1A, and inserted into a luciferase reporter vector (pGL3). Skin fibroblasts were explanted from two SSc patients whose genomic DNA contained GG and TT genotypes at +4845 of the IL1A gene, respectively. Cell lysates were collected and reacted with various concentrations of calpain, and then the processing of pre-IL-1alpha was analyzed by Western blotting using monoclonal anti-IL-1alpha antibody. A SNP was determined by the allelic discrimination method using fluorescence-labeled Taq-Man probes. Significant differences in the luciferase activities were not detected between pGL3 (C/IL1A) and pGL3 (T/IL1A) in SSc fibroblasts. Calpain required a 100-fold higher concentration to process the pre-IL-1alpha containing Ala at the 114th amino acid than that to do containing Ser. The frequency of the GG genotype was significantly higher in SSc patients than that in healthy donors, whereas the frequency of TT genotype was significantly higher in RA patients than that in healthy donors. Our observation showed that the SNP at +4845 affected the enzymatic efficiency of the protease in cleaving pre-IL-1alpha. Pre-IL-1alpha with Ala, which was high in frequency in SSc patients, was more resistant to be cleaved by proteases in human sera than pro-IL-1alpha with Ser.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440718     DOI: 10.1007/s00251-007-0213-y

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   3.330


  37 in total

1.  Association between the interleukin-1alpha gene and Alzheimer's disease: a meta-analysis.

Authors:  I Rainero; M Bo; M Ferrero; W Valfrè; G Vaula; L Pinessi
Journal:  Neurobiol Aging       Date:  2004 Nov-Dec       Impact factor: 4.673

2.  Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts.

Authors:  Yasushi Kawaguchi; Emi Nishimagi; Akiko Tochimoto; Manabu Kawamoto; Yasuhiro Katsumata; Makoto Soejima; Tokiko Kanno; Naoyuki Kamatani; Masako Hara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

3.  Association between allelic variants in cytokine genes and preeclampsia.

Authors:  Catherine L Haggerty; Robert E Ferrell; Carl A Hubel; Nina Markovic; Gail Harger; Roberta B Ness
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

4.  Possible genetic association between interleukin-1alpha gene polymorphism and the severity of chronic polyarthritis.

Authors:  P Jouvenne; A Chaudhary; N Buchs; F S Giovine; G W Duff; P Miossec
Journal:  Eur Cytokine Netw       Date:  1999-03       Impact factor: 2.737

5.  DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.

Authors:  Jill Hénault; Geneviève Robitaille; Jean-Luc Senécal; Yves Raymond
Journal:  Arthritis Rheum       Date:  2006-03

6.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

7.  C-reactive protein levels are influenced by common IL-1 gene variations.

Authors:  Peter Berger; Joseph P McConnell; Martha Nunn; Kenneth S Kornman; Julian Sorrell; Katherine Stephenson; Gordon W Duff
Journal:  Cytokine       Date:  2002-02-21       Impact factor: 3.861

8.  The IL1A genotype associates with atopy in nonasthmatic adults.

Authors:  Jussi Karjalainen; Janne Hulkkonen; Tanja Pessi; Heini Huhtala; Markku M Nieminen; Arpo Aromaa; Timo Klaukka; Mikko Hurme
Journal:  J Allergy Clin Immunol       Date:  2002-09       Impact factor: 10.793

9.  A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism.

Authors:  T L McDowell; J A Symons; R Ploski; O Førre; G W Duff
Journal:  Arthritis Rheum       Date:  1995-02

Review 10.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

View more
  13 in total

Review 1.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

2.  Association of interleukin 1 family with systemic sclerosis.

Authors:  Li Zhang; Jun-Wei Yan; Yu-Jie Wang; Ya-Nan Wan; Bing-Xiang Wang; Jin-Hui Tao; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

3.  Gender difference in genetic association between IL1A variant and early lumbar disc degeneration: a three-year follow-up.

Authors:  Pasi J Eskola; Per Kjaer; Joan S Sorensen; Annaleena Okuloff; Niels Wedderkopp; Iita Daavittila; Leena Ala-Kokko; Minna Männikkö; Jaro Karppinen
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

4.  Association between IL1A and IL1B polymorphisms and primary open angle glaucoma in a Brazilian population.

Authors:  Mariana B Oliveira; José Paulo C de Vasconcellos; Galina Ananina; Vital P Costa; Mônica B de Melo
Journal:  Exp Biol Med (Maywood)       Date:  2018-09

5.  Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.

Authors:  Nicholas T Woods; Alvaro N Monteiro; Zachary J Thompson; Ernest K Amankwah; Nina Naas; Eric B Haura; Amer A Beg; Matthew B Schabath
Journal:  Mol Carcinog       Date:  2015-01-18       Impact factor: 4.784

Review 6.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 7.  Function and regulation of IL-1α in inflammatory diseases and cancer.

Authors:  Ankit Malik; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

8.  Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.

Authors:  Michelle A T Hildebrandt; Ritsuko Komaki; Zhongxing Liao; Jian Gu; Joe Y Chang; Yuanqing Ye; Charles Lu; David J Stewart; John D Minna; Jack A Roth; Scott M Lippman; James D Cox; Waun Ki Hong; Margaret R Spitz; Xifeng Wu
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

9.  Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and mice.

Authors:  Jae-Young Um; Hong-Kun Rim; Su-Jin Kim; Hye-Lin Kim; Seung-Heon Hong
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

10.  Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

Authors:  Bridget Charbonneau; Matthew S Block; William R Bamlet; Robert A Vierkant; Kimberly R Kalli; Zachary Fogarty; David N Rider; Thomas A Sellers; Shelley S Tworoger; Elizabeth Poole; Harvey A Risch; Helga B Salvesen; Lambertus A Kiemeney; Laura Baglietto; Graham G Giles; Gianluca Severi; Britton Trabert; Nicolas Wentzensen; Georgia Chenevix-Trench; Alice S Whittemore; Weiva Sieh; Jenny Chang-Claude; Elisa V Bandera; Irene Orlow; Kathryn Terry; Marc T Goodman; Pamela J Thompson; Linda S Cook; Mary Anne Rossing; Roberta B Ness; Steven A Narod; Jolanta Kupryjanczyk; Karen Lu; Ralf Butzow; Thilo Dörk; Tanja Pejovic; Ian Campbell; Nhu D Le; Clareann H Bunker; Natalia Bogdanova; Ingo B Runnebaum; Diana Eccles; James Paul; Anna H Wu; Simon A Gayther; Estrid Hogdall; Florian Heitz; Stanley B Kaye; Beth Y Karlan; Hoda Anton-Culver; Jacek Gronwald; Claus K Hogdall; Diether Lambrechts; Peter A Fasching; Usha Menon; Joellen Schildkraut; Celeste Leigh Pearce; Douglas A Levine; Susanne Kruger Kjaer; Daniel Cramer; James M Flanagan; Catherine M Phelan; Robert Brown; Leon F A G Massuger; Honglin Song; Jennifer A Doherty; Camilla Krakstad; Dong Liang; Kunle Odunsi; Andrew Berchuck; Allan Jensen; Jan Lubinski; Heli Nevanlinna; Yukie T Bean; Galina Lurie; Argyrios Ziogas; Christine Walsh; Evelyn Despierre; Louise Brinton; Alexander Hein; Anja Rudolph; Agnieszka Dansonka-Mieszkowska; Sara H Olson; Philipp Harter; Jonathan Tyrer; Allison F Vitonis; Angela Brooks-Wilson; Katja K Aben; Malcolm C Pike; Susan J Ramus; Elisabeth Wik; Cezary Cybulski; Jie Lin; Lara Sucheston; Robert Edwards; Valerie McGuire; Jenny Lester; Andreas du Bois; Lene Lundvall; Shan Wang-Gohrke; Lukasz M Szafron; Sandrina Lambrechts; Hannah Yang; Matthias W Beckmann; Liisa M Pelttari; Anne M Van Altena; David van den Berg; Mari K Halle; Aleksandra Gentry-Maharaj; Ira Schwaab; Urmila Chandran; Janusz Menkiszak; Arif B Ekici; Lynne R Wilkens; Arto Leminen; Francesmary Modugno; Grace Friel; Joseph H Rothstein; Ignace Vergote; Montserrat Garcia-Closas; Michelle A T Hildebrandt; Piotr Sobiczewski; Linda E Kelemen; Paul D P Pharoah; Kirsten Moysich; Keith L Knutson; Julie M Cunningham; Brooke L Fridley; Ellen L Goode
Journal:  Cancer Res       Date:  2013-11-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.